Emma L. Lane

Affiliations: 
Cardiff University, Cardiff, Wales, United Kingdom 
Area:
Parkinson's disease, dyskinesia
Google:
"Emma Lane"
Mean distance: 14.8 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lelos MJ, Murphy EM, Lindgren HS, et al. (2023) Impaired cognitive and motor function are coincident with L-DOPA-induced dyskinesia in a model of Parkinson's disease. Scientific Reports. 13: 17697
Lane EL, Lelos MJ. (2022) Defining the unknowns for cell therapies in Parkinson's disease. Disease Models & Mechanisms. 15
Elabi OF, Pass R, Sormonta I, et al. (2022) Human Embryonic Stem Cell-Derived Dopaminergic Grafts Alleviate L-DOPA Induced Dyskinesia. Journal of Parkinson's Disease
Elabi OF, Davies JS, Lane EL. (2021) L-dopa-Dependent Effects of GLP-1R Agonists on the Survival of Dopaminergic Cells Transplanted into a Rat Model of Parkinson Disease. International Journal of Molecular Sciences. 22
Lane EL, Harrison DJ, Ramos-Varas E, et al. (2021) Spontaneous Graft-Induced Dyskinesias Are Independent of 5-HT Neurons and Levodopa Priming in a Model of Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society
Precious SV, Smith GA, Heuer A, et al. (2020) Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson's Disease Model. Frontiers in Neuroscience. 14: 312
Orayj K, Lane E. (2019) Patterns and Determinants of Prescribing for Parkinson's Disease: A Systematic Literature Review. Parkinson's Disease. 2019: 9237181
Orayj K, Lacey A, Akbari A, et al. (2019) Association between levodopa and ischemic heart disease International Journal of Population Data Science. 4
Elabi OF, Duskova K, Davies JS, et al. (2018) The Impact of Ghrelin on the Survival and Efficacy of Dopaminergic Fetal Grafts in the 6-OHDA-Lesioned Rat. Neuroscience
Lane EL. (2018) L-DOPA for Parkinson's disease - a bittersweet pill. The European Journal of Neuroscience
See more...